Researchers led by Yang, T. and Wang, YY have unveiled an artificial intelligence approach that creates virtual cell models simulating intricate human cellular behaviors. These models enable faster discovery and preclinical testing by computationally screening drug candidates and predicting biological outcomes. The integration of AI with biology accelerates translational research, potentially reducing reliance on traditional lab experiments. This pioneering work signals a paradigm shift toward digital twins of human cells for precision medicine and cancer therapeutics.